Related references
Note: Only part of the references are listed.A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRA®
John A. Kanis et al.
BONE (2010)
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
Pierre J. Marie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
Harry K. Genant et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Vertebral fracture assessment using a semiquantitative technique
Harry K. Genant et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
J. Collette et al.
OSTEOPOROSIS INTERNATIONAL (2010)
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns
B. Dawson-Hughes et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
John A. Kanis et al.
BONE (2009)
Osteoblasts play key roles in the mechanisms of action of strontium ranelate
T. C. Brennan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis NEW INSIGHTS INTO THE ASSOCIATED SIGNALING PATHWAYS
Anne S. Hurtel-Lemaire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Could Strontium Ranelate Have a Synergistic Role in the Treatment of Osteoporosis?
Glen M. Blake et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants
S. D. Bain et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study
E. V. McCloskey et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
P. J. Meunier et al.
OSTEOPOROSIS INTERNATIONAL (2009)
FRAX™ and the assessment of fracture probability in men and women from the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Histomorphometric and μCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate
Monique E. Arlot et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength
Patrick Ammann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation
Naibedya Chattopadhyay et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Strontium ranelate: New insights into its dual mode of action
Pierre J. Marie
BONE (2007)
Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: Results of a double-blind, placebo-controlled randomized study
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors
C Roux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
JY Reginster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
PJ Meunier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats
P Ammann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Strontium ranelate: Dose-dependent effects in established postmenopausal vertebral osteoporosis - A 2-year randomized placebo controlled trial
PJ Meunier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Mechanisms of action and therapeutic potential of strontium in bone
PJ Marie et al.
CALCIFIED TISSUE INTERNATIONAL (2001)
Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis)
J Buehler et al.
BONE (2001)
The burden of osteoporotic fractures: A method for setting intervention thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Share Paper
